Provider Intervention for Pediatric Sickle Cell Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how teaching healthcare providers specific communication skills might enhance interactions with children who have sickle cell disease (SCD). The focus is on skills such as individuation (seeing each patient as unique) and perspective-taking (understanding a patient's viewpoint). The trial will compare two groups of providers: one learning these skills and another learning about managing SCD pain. Providers who work with children with SCD at certain hospitals and are not currently trainees may be eligible to participate. As an unphased trial, this study offers a unique opportunity to contribute to improving healthcare communication for children with SCD.
Do I have to stop taking my current medications for this trial?
The trial does not specify whether participants need to stop taking their current medications.
What prior data suggests that this intervention is safe for health care providers?
Research has shown that the individuation and perspective-taking (IPT) program for healthcare providers is well-received. Early studies found that IPT is practical and acceptable for participants. These studies suggest that the program does not cause major side effects, making it safe for healthcare providers. The program aims to improve communication with patients, potentially leading to better healthcare outcomes for children with sickle cell disease. Overall, evidence supports the safety of IPT, as participants have responded positively.12345
Why are researchers excited about this trial?
Researchers are excited about the Provider Intervention for Pediatric Sickle Cell Disease because it introduces a fresh perspective on managing this condition. Unlike traditional treatments that focus on medications and physical interventions, this approach emphasizes the psychological aspect by training healthcare providers in individuation and perspective-taking (IPT). This means providers learn to see each patient as unique and to understand their experiences more deeply, potentially improving patient-provider relationships and pain management outcomes. This trial could uncover significant benefits in patient care by enhancing empathy and personalized treatment strategies, which are not the focus of current standard methods.
What evidence suggests that this intervention is effective for improving patient-centered communication in pediatric sickle cell disease?
Research has shown that individuation and perspective-taking (IPT) can enhance communication between doctors, nurses, and patients with sickle cell disease (SCD). In this trial, healthcare providers in the IPT intervention arm will attend a virtual session on the IPT method. An early study found that healthcare providers working with children who have SCD found IPT easy to use and favorable. This method aims to reduce unconscious bias and improve patient-centered care, potentially leading to better health outcomes. Enhanced communication between healthcare providers and patients may result in more personalized treatment plans and fewer misunderstandings. Early findings suggest that improved communication can build trust, which may help patients adhere to their treatment plans.12356
Who Is on the Research Team?
Siddika Mulchan, PsyD
Principal Investigator
Connecticut Children's Medical Center
Are You a Good Fit for This Trial?
This trial is for licensed health care providers who care for children with sickle cell disease and work mainly in Hematology/Oncology at Connecticut Children's, Yale New Haven Children's Hospital, or Children's Hospital of Philadelphia.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Health care providers participate in a 90-minute virtual training session on individuation and perspective-taking (IPT) skills
Control
Health care providers attend a virtual presentation on didactic information about best practices in pediatric SCD pain management
Follow-up
Participants are monitored for changes in patient-centered communication and empathy using MPCC and IRI measures
What Are the Treatments Tested in This Trial?
Interventions
- Individuation and Perspective-Taking (IPT)
Trial Overview
The study compares two training sessions for these providers: one teaches skills to better understand and connect with patients (IPT), while the other focuses on pain management education. Providers are randomly assigned to either group.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Health care provider participants will attend a virtual session presenting the IPT intervention.
Health care provider participants will attend a virtual presentation on didactic information about best practices in pediatric SCD pain management.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Connecticut Children's Medical Center
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Children's Hospital of Philadelphia
Collaborator
Yale-New Haven Children's Hospital
Collaborator
Citations
1.
trial.medpath.com
trial.medpath.com/clinical-trial/d71712381ce5996d/nct07540767-provider-intervention-improve-health-pediatric-sickle-cell-diseaseDevelopment of a Provider-Focused Intervention to ... - MedPath
We developed and piloted an individuation and perspective-taking (IPT) intervention for pediatric SCD HCPs. IPT currently consists of one 90- ...
Initial evaluation of an intervention to address provider ...
Aims : The aim of this study was to evaluate the feasibility, acceptability, and preliminary impact of an individuation and perspective-taking (IPT) ...
Study Details | NCT07540767 | Development of a Provider ...
The goal of this interventional study is to learn about the impact of an intervention for health care providers that teaches individuation and ...
Initial evaluation of an intervention to address provider implicit ...
: The aim of this study was to evaluate the feasibility, acceptability, and preliminary impact of an individuation and perspective-taking (IPT) ...
5.
scholarworks.umb.edu
scholarworks.umb.edu/cgi/viewcontent.cgi?article=1024&context=nursing_dnp_capstoneImproving Access to Non-Pharmacologic Integrative Pain ...
The project aims to improve access to preferred modalities for integrative pain management among hospitalized Sickle Cell Disease (SCD).
Provider Intervention for Pediatric Sickle Cell Disease
... Individuation and Perspective-Taking (IPT) will have tolerable side effects & efficacy for patients with Sickle Cell Disease, Sickle Cell ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.